Pfizer hemophilia gene therapy meets Phase 3 goals

The latest stories trending on MedCity News.

Editor's Pick

Top Story Pfizer Hemophilia Gene Therapy Meets Phase 3 Goals, But Its Success Matters More to Sangamo Pfizer's hemophilia A gene therapy reduced annualized bleeding rates in a Phase 3 clinical trial, setting the stage for discussions with regulators. However, the market for such one-time treatments is uncertain, as uptake of commercialized hemophilia gene therapies remains slow. Sponsored Integrated Enrollment Platforms and Consumer Assistance Centers: The Strongest Advantage for State-Based Exchanges Presented by GetInsured In the ever-evolving landscape of state-based health insurance exchanges, the convergence of technology and customer service is reshaping how these exchanges operate. The increasing advent of automation and artificial intelligence (AI) is rapidly dismantling the traditional business model that relies on the siloing of technology and customer service centers. Learn More INVEST Digital Health: Are You Ready to Connect with the Brightest Minds in Healthcare Tech? Expand your professional connections, create meaningful partnerships, and unlock new possibilities for your business and career. Join the MedCity community of thinkers and doers – secure your spot at INVEST Digital Health today and be part of the conversations that will happen on September 18 at Pegasus Park, Dallas! Get Your Ticket Today, Save $100

Featured News

MedCity Pivot Podcast: Eye As the Window to Your Health With Vicky Demas Vicky Demas, CEO of identifeye Health, talks about the company's approach to probe the retina with its proprietary device and companion algorithm. The reitna, she believes, holds the clues to overall health. Cigna Addresses Health Disparities Through $9M Commitment Cigna announced the launch of the Cigna Group Health Equity Impact Fund and committed $9 million on Monday. It will focus on health disparities in Houston, Texas, and Hartford, Connecticut. ​​Restoring Public Trust in the Biopharma Industry: The Role of Advanced Analytics Misinformation and disinformation are rampant, placing companies under unprecedented pressure to preserve their reputation. Here are some steps to protect your company's reputation. The Right to Privacy — What a Novel Concept The current piecemeal state-by-state regulation approach is a feeble patchwork and ready for collapse under the first strong blow. It's high time we craft a robust and uniform effort to safeguard our patients' digital rights. Patients Want Personalized Digital Experiences. Could a Modular Back End Help? To personalize the patient journey, hospitals need a digital back end capable of delivering tailored experiences. Here's how a composable digital experience platform (DXP) works and how it can help you offer multiple layers of personalization to meet your patient's needs.

Resources

AI in Healthcare: The Next Chapter The shifting AI landscape. Learn about the emerging technologies from AI tech developers across the healthcare landscape from health tech startups to healthcare organizations, biopharma companies, and a medtech giant. Download Now

MedCity News • PO Box 901 • New York, NY unsubscribe